69164-74-5 Usage
Uses
Used in Pharmaceutical Industry:
Benzyl 7-[(benzyloxy)carbonyl]-9-oxo-11-phenyl-10-oxa-4-thia-2,3,8-triazaundecan-1-oate 4,4-dioxide is used as a pharmaceutical intermediate for the synthesis of various therapeutic agents. Its complex structure and functional groups enable the development of new drugs with unique properties and potential therapeutic benefits.
Used in Organic Synthesis:
In the field of organic synthesis, benzyl 7-[(benzyloxy)carbonyl]-9-oxo-11-phenyl-10-oxa-4-thia-2,3,8-triazaundecan-1-oate 4,4-dioxide serves as a versatile building block for the creation of more complex organic molecules. Its multiple functional groups allow for various chemical reactions, enabling the synthesis of a wide range of compounds with diverse applications.
Used in Chemical Research:
Benzyl 7-[(benzyloxy)carbonyl]-9-oxo-11-phenyl-10-oxa-4-thia-2,3,8-triazaundecan-1-oate 4,4-dioxide is utilized in chemical research to explore its properties, reactivity, and potential applications. Its unique structure and functional groups provide opportunities for studying new reaction mechanisms, developing novel synthetic methods, and discovering new chemical transformations.
Check Digit Verification of cas no
The CAS Registry Mumber 69164-74-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,1,6 and 4 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 69164-74:
(7*6)+(6*9)+(5*1)+(4*6)+(3*4)+(2*7)+(1*4)=155
155 % 10 = 5
So 69164-74-5 is a valid CAS Registry Number.
69164-74-5Relevant academic research and scientific papers
Potential antitumor agents via inhibitors of L-asparagine synthetase: substituted sulfonamides and sulfonyl hydrazides related to glutamine
Brynes,Fiorina,Cooney,Milman
, p. 1550 - 1553 (2007/10/13)
A series of 4-(substituted aminosulfonyl)- and 4-(substituted hydrazinosulfonyl)-2-aminobutanoic acids, compounds structurally related to glutamine, was synthesized as potential inhibitors of L-asparagine synthetase and subjected to screening as antitumor agents. Target amino acids were obtained by condensation of a blocked reactive sulfonyl chloride with the appropriate amine or hydrazide, followed by deblocking with hydrogen-palladium or liquid hydrogen fluoride-anisole. Neither the target compounds nor their protected precursors inhibited the enzyme from L5178Y/AR or prolonged the life of mice with P-388 lymphocytic leukemia. However, DL-4,4'-dithiobis[2-(benzyloxycarbonylamino)-butanoic acid], an intermediate in the synthesis of the target amino acids, exhibited 90% inhibition of L-asparagine synthetase at 10 mM.
